Copyright Reports & Markets. All rights reserved.

Global Immune in Vitro Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immune in Vitro Diagnostics by Type
    • 1.3.1 Overview: Global Immune in Vitro Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Immune in Vitro Diagnostics Consumption Value Market Share by Type in 2025
    • 1.3.3 Consumables
    • 1.3.4 Equipment
  • 1.4 Global Immune in Vitro Diagnostics Market by Application
    • 1.4.1 Overview: Global Immune in Vitro Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hepatitis Test
    • 1.4.3 STD Testing
    • 1.4.4 Tumor Detection
    • 1.4.5 Other
  • 1.5 Global Immune in Vitro Diagnostics Market Size & Forecast
  • 1.6 Global Immune in Vitro Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Immune in Vitro Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Immune in Vitro Diagnostics Market Size by Region, (2021-2032)
    • 1.6.3 North America Immune in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Immune in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Immune in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.6 South America Immune in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Immune in Vitro Diagnostics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Immune in Vitro Diagnostics Product and Solutions
    • 2.1.4 Roche Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Siemens
    • 2.2.1 Siemens Details
    • 2.2.2 Siemens Major Business
    • 2.2.3 Siemens Immune in Vitro Diagnostics Product and Solutions
    • 2.2.4 Siemens Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Siemens Recent Developments and Future Plans
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Immune in Vitro Diagnostics Product and Solutions
    • 2.3.4 Abbott Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abbott Recent Developments and Future Plans
  • 2.4 Danaher
    • 2.4.1 Danaher Details
    • 2.4.2 Danaher Major Business
    • 2.4.3 Danaher Immune in Vitro Diagnostics Product and Solutions
    • 2.4.4 Danaher Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Danaher Recent Developments and Future Plans
  • 2.5 Thermo Fisher
    • 2.5.1 Thermo Fisher Details
    • 2.5.2 Thermo Fisher Major Business
    • 2.5.3 Thermo Fisher Immune in Vitro Diagnostics Product and Solutions
    • 2.5.4 Thermo Fisher Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermo Fisher Recent Developments and Future Plans
  • 2.6 BioMerieux
    • 2.6.1 BioMerieux Details
    • 2.6.2 BioMerieux Major Business
    • 2.6.3 BioMerieux Immune in Vitro Diagnostics Product and Solutions
    • 2.6.4 BioMerieux Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BioMerieux Recent Developments and Future Plans
  • 2.7 Bio-Rad
    • 2.7.1 Bio-Rad Details
    • 2.7.2 Bio-Rad Major Business
    • 2.7.3 Bio-Rad Immune in Vitro Diagnostics Product and Solutions
    • 2.7.4 Bio-Rad Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio-Rad Recent Developments and Future Plans
  • 2.8 BD
    • 2.8.1 BD Details
    • 2.8.2 BD Major Business
    • 2.8.3 BD Immune in Vitro Diagnostics Product and Solutions
    • 2.8.4 BD Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BD Recent Developments and Future Plans
  • 2.9 KHB
    • 2.9.1 KHB Details
    • 2.9.2 KHB Major Business
    • 2.9.3 KHB Immune in Vitro Diagnostics Product and Solutions
    • 2.9.4 KHB Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 KHB Recent Developments and Future Plans
  • 2.10 Daan Gene
    • 2.10.1 Daan Gene Details
    • 2.10.2 Daan Gene Major Business
    • 2.10.3 Daan Gene Immune in Vitro Diagnostics Product and Solutions
    • 2.10.4 Daan Gene Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Daan Gene Recent Developments and Future Plans
  • 2.11 Leadman
    • 2.11.1 Leadman Details
    • 2.11.2 Leadman Major Business
    • 2.11.3 Leadman Immune in Vitro Diagnostics Product and Solutions
    • 2.11.4 Leadman Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Leadman Recent Developments and Future Plans
  • 2.12 Zhongsheng
    • 2.12.1 Zhongsheng Details
    • 2.12.2 Zhongsheng Major Business
    • 2.12.3 Zhongsheng Immune in Vitro Diagnostics Product and Solutions
    • 2.12.4 Zhongsheng Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhongsheng Recent Developments and Future Plans
  • 2.13 Bsbe
    • 2.13.1 Bsbe Details
    • 2.13.2 Bsbe Major Business
    • 2.13.3 Bsbe Immune in Vitro Diagnostics Product and Solutions
    • 2.13.4 Bsbe Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Bsbe Recent Developments and Future Plans
  • 2.14 Maccura
    • 2.14.1 Maccura Details
    • 2.14.2 Maccura Major Business
    • 2.14.3 Maccura Immune in Vitro Diagnostics Product and Solutions
    • 2.14.4 Maccura Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Maccura Recent Developments and Future Plans
  • 2.15 Hitachi
    • 2.15.1 Hitachi Details
    • 2.15.2 Hitachi Major Business
    • 2.15.3 Hitachi Immune in Vitro Diagnostics Product and Solutions
    • 2.15.4 Hitachi Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hitachi Recent Developments and Future Plans
  • 2.16 Canon
    • 2.16.1 Canon Details
    • 2.16.2 Canon Major Business
    • 2.16.3 Canon Immune in Vitro Diagnostics Product and Solutions
    • 2.16.4 Canon Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Canon Recent Developments and Future Plans
  • 2.17 Sysmex
    • 2.17.1 Sysmex Details
    • 2.17.2 Sysmex Major Business
    • 2.17.3 Sysmex Immune in Vitro Diagnostics Product and Solutions
    • 2.17.4 Sysmex Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Sysmex Recent Developments and Future Plans
  • 2.18 Auto Bio
    • 2.18.1 Auto Bio Details
    • 2.18.2 Auto Bio Major Business
    • 2.18.3 Auto Bio Immune in Vitro Diagnostics Product and Solutions
    • 2.18.4 Auto Bio Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Auto Bio Recent Developments and Future Plans
  • 2.19 Mindray
    • 2.19.1 Mindray Details
    • 2.19.2 Mindray Major Business
    • 2.19.3 Mindray Immune in Vitro Diagnostics Product and Solutions
    • 2.19.4 Mindray Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Mindray Recent Developments and Future Plans
  • 2.20 Bgi
    • 2.20.1 Bgi Details
    • 2.20.2 Bgi Major Business
    • 2.20.3 Bgi Immune in Vitro Diagnostics Product and Solutions
    • 2.20.4 Bgi Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Bgi Recent Developments and Future Plans
  • 2.21 Wondfo
    • 2.21.1 Wondfo Details
    • 2.21.2 Wondfo Major Business
    • 2.21.3 Wondfo Immune in Vitro Diagnostics Product and Solutions
    • 2.21.4 Wondfo Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Wondfo Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immune in Vitro Diagnostics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Immune in Vitro Diagnostics by Company Revenue
    • 3.2.2 Top 3 Immune in Vitro Diagnostics Players Market Share in 2025
    • 3.2.3 Top 6 Immune in Vitro Diagnostics Players Market Share in 2025
  • 3.3 Immune in Vitro Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Immune in Vitro Diagnostics Market: Region Footprint
    • 3.3.2 Immune in Vitro Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Immune in Vitro Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immune in Vitro Diagnostics Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Immune in Vitro Diagnostics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Immune in Vitro Diagnostics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Immune in Vitro Diagnostics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Immune in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 6.2 North America Immune in Vitro Diagnostics Market Size by Application (2021-2032)
  • 6.3 North America Immune in Vitro Diagnostics Market Size by Country
    • 6.3.1 North America Immune in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 6.3.2 United States Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Immune in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 7.2 Europe Immune in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 7.3 Europe Immune in Vitro Diagnostics Market Size by Country
    • 7.3.1 Europe Immune in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.3 France Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immune in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Immune in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Immune in Vitro Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Immune in Vitro Diagnostics Consumption Value by Region (2021-2032)
    • 8.3.2 China Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.5 India Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Immune in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 9.2 South America Immune in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 9.3 South America Immune in Vitro Diagnostics Market Size by Country
    • 9.3.1 South America Immune in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immune in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Immune in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Immune in Vitro Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Immune in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Immune in Vitro Diagnostics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Immune in Vitro Diagnostics Market Drivers
  • 11.2 Immune in Vitro Diagnostics Market Restraints
  • 11.3 Immune in Vitro Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immune in Vitro Diagnostics Industry Chain
  • 12.2 Immune in Vitro Diagnostics Upstream Analysis
  • 12.3 Immune in Vitro Diagnostics Midstream Analysis
  • 12.4 Immune in Vitro Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Immune in Vitro Diagnostics market size was valued at US$ 27370 million in 2025 and is forecast to a readjusted size of US$ 42880 million by 2032 with a CAGR of 6.7% during review period.
    Immune in vitro diagnostics (IVD) involve the examination of components related to the immune system, often using laboratory tests performed on biological samples taken from the human body. These tests play a crucial role in understanding the immune response, diagnosing immunological disorders, monitoring the effectiveness of treatments, and assessing overall immune health.
    The Immune In Vitro Diagnostics market is propelled by a growing demand for advanced diagnostic tools to assess the immune system"s functionality and response. With the increasing incidence of immune-related disorders, including autoimmune diseases and allergies, there is a heightened need for accurate and timely diagnostics. Immune in vitro diagnostic devices, such as immunoassays, flow cytometry, and molecular diagnostics, play a crucial role in evaluating immune biomarkers. The market is driven by ongoing research in immunology, leading to the development of more specific and sensitive diagnostic technologies. Additionally, a focus on personalized medicine and treatment strategies contributes to the continuous evolution and adoption of immune in vitro diagnostics in clinical practice.
    This report is a detailed and comprehensive analysis for global Immune in Vitro Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Immune in Vitro Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Immune in Vitro Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Immune in Vitro Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Immune in Vitro Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Immune in Vitro Diagnostics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Immune in Vitro Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, KHB, Daan Gene, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Immune in Vitro Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Consumables
    Equipment
    Market segment by Application
    Hepatitis Test
    STD Testing
    Tumor Detection
    Other
    Market segment by players, this report covers
    Roche
    Siemens
    Abbott
    Danaher
    Thermo Fisher
    BioMerieux
    Bio-Rad
    BD
    KHB
    Daan Gene
    Leadman
    Zhongsheng
    Bsbe
    Maccura
    Hitachi
    Canon
    Sysmex
    Auto Bio
    Mindray
    Bgi
    Wondfo
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Immune in Vitro Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Immune in Vitro Diagnostics, with revenue, gross margin, and global market share of Immune in Vitro Diagnostics from 2021 to 2026.
    Chapter 3, the Immune in Vitro Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immune in Vitro Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Immune in Vitro Diagnostics.
    Chapter 13, to describe Immune in Vitro Diagnostics research findings and conclusion.

    Buy now